Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Clin Exp Immunol ; 146(2): 344-53, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17034588

ABSTRACT

Vaccinia virus (VV) has been tested as oncolytic virus against malignant melanoma in clinical trials for more than 40 years. Until now, mainly strains comparable to viral strains used for smallpox vaccination have been probed for anti-tumoral therapy. We have shown recently that the wild-type strain Western Reserve (WR) can interfere with crucial functions of monocyte-derived dendritic cells (DCs). Our aim was to examine whether viral immune evasion mechanisms might be responsible for the ineffectiveness of WR-based vaccination strategies and whether the highly attenuated strain modified virus Ankara (MVA) differs from WR with respect to its possible immunostimulatory capacity after intratumoral injection. Using in vitro experiments, we compared the effect of both strains on melanoma cells and on local bystander DCs. We found that both VV-strains infected melanoma cells efficiently and caused disintegration of the actin cytoskeleton, as shown by fluorescence microscopy. In addition, both VV-strains caused apoptotic cell death in melanoma cells after infection. In contrast to MVA, WR underwent a complete viral replication cycle in melanoma cells. Bystander DCs were consecutively infected by newly generated WR virions and lost their capacity to induce allogeneic T cell proliferation. DCs in contact with MVA-infected melanoma cells retained their capacity to induce T cell proliferation. Immature DCs were capable of phagocytosing MVA-infected melanoma cells. Priming of autologous CD8(+) T cells by DCs that had phagocytosed MVA-infected, MelanA positive melanoma cells resulted in the induction of T cell clones specifically reactive against the model antigen MelanA as shown by enzyme-linked immunospot (ELISPOT) analysis. We conclude that the clinical trials with oncolytic wild-type VV failed probably because of suppression of bystander DCs and consecutive suppression of T cell-mediated anti-melanoma immunity. The attenuated VV-strain MVA facilitates the generation of tumour associated antigen (TAA)-specific T cell response as it is oncolytic for melanoma cells, but non-toxic for DC, and should be a promising candidate for intralesional metastatic melanoma therapy.


Subject(s)
Apoptosis/immunology , Cancer Vaccines/immunology , Dendritic Cells/immunology , Melanoma/immunology , Vaccinia virus/immunology , Actins/metabolism , Bystander Effect/immunology , Cytoskeleton/pathology , Humans , Melanoma/pathology , Melanoma/virology , Phagocytosis , Tumor Cells, Cultured , Vaccines, Attenuated/immunology , Vaccinia virus/classification , Vaccinia virus/physiology , Virus Replication
2.
Acta Crystallogr A ; 50 ( Pt 2): 203-10, 1994 Mar 01.
Article in English | MEDLINE | ID: mdl-8166951

ABSTRACT

Eliminating the N atomic position vectors rj, j = 1, 2, ..., N, from the system of equations defining the normalized structure factors EH yields a system of identities that the EH's must satisfy, provided that the set of EH's is sufficiently large. Clearly, for fixed N and specified space group, this system of identities depends only on the set [H], consisting of n reciprocal-lattice vectors H, and is independent of the crystal structure, which is assumed for simplicity to consist of N identical atoms per unit cell. However, for a fixed crystal structure, the magnitudes magnitude of /EH/ are uniquely determined so that a system of identities is obtained among the corresponding phases psi H alone, which depends on the presumed known magnitudes magnitude of /EH/ and which must of necessity be satisfied. The known conditional probability distributions of triplets and quartets, given the values of certain magnitudes magnitude of /E/, lead to a function R(psi) of phases, uniquely determined by magnitudes magnitude of /E/ and having the property that RT < 1/2 < RR, where RT is the value of R(psi) when the phases are equal to their true values, no matter what the choice of origin and enantiomorph, and RR is the value of R(psi) when the phases are chosen at random. The following conjecture is therefore plausible: the global minimum of R(psi), where the phases are constrained to satisfy all identities among them that are known to exist, is attained when the phases are equal to their true values and is thus equal to RT.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Crystallography, X-Ray , Fourier Analysis , Molecular Conformation
3.
Acta Crystallogr A ; 50 ( Pt 2): 210-20, 1994 Mar 01.
Article in English | MEDLINE | ID: mdl-8166952

ABSTRACT

The minimal function, R(psi), has been used to provide the basis for a new computer-intensive direct-methods procedure that shows potential for providing fully automatic routine solutions for structures in the 200-400 atom range. This procedure, which has been called shake-and-bake, is an iterative process in which real-space filtering is alternated with phase refinement using a technique that reduces the value of R(psi). It has been successfully tested using experimental data for a dozen known structures ranging in size from 25 to 317 atoms and crystallizing in a variety of space groups. The details of this procedure, the parameters used and the results of these applications are described.


Subject(s)
Crystallography, X-Ray , Fourier Analysis , Computers , Models, Chemical , Models, Statistical , Molecular Conformation
4.
J Aud Res ; 23(2): 131-5, 1983 Apr.
Article in English | MEDLINE | ID: mdl-6679549

ABSTRACT

This investigation provided data on the performance of 94 men and women (24 aged 18-24 yrs, 24 aged 60-66 yrs, 24 aged 67-73 yrs and 22 aged 74-80 yrs) presented a tape recording of Willeford's Central Auditory Processing Test Battery (Audiol. Hear. Educ., 1976, 2, 12-20) kindly provided by Willeford. Significant effects for age and sex and/or ear were obtained on all subtests and lists, thereby suggesting the need to control these factors as a clinical test version when associated normative data are developed.


Subject(s)
Speech Discrimination Tests/methods , Adolescent , Adult , Age Factors , Aged , Female , Humans , Male , Middle Aged , Reference Values , Sex Factors , Speech Perception
SELECTION OF CITATIONS
SEARCH DETAIL
...